Thriftonista

Category: Cancer Research

In Pursuit of Greatness: Cancer Treatment Centers of America

The fight against cancer is going strong into the 21st century. Fortunately, there are many organization out there that are making huge progress in defeating cancer. Just over the past decade, there have…

Treatment Options for Fighting against Cancer

Cancer is a deadly disease that kills millions each year. This dangerous disease comes in many different forms. There are lung, breast, colon and bone cancer conditions. Each of these cancerous ailments have…

Cancer Treatment Centers of America Excited About A Unique Oncology Data Platform

Having the right information when needed can make all of the difference. Cancer Treatment Centers of America has recognized this, and they combined resources with partners Allscripts and Nanthealth to unroll a brand…

Fighting Multiple Sclerosis – Hope in Stem Cell Transplants

There is a wide range of multiple sclerosis (MS) symptoms including chronic pain, motor and speech difficulties, weakness, and fatigue. In most patients, these symptoms are periodical and worsen with time; this condition…

An Insight into Seattle Genetics’s Impressive Plan to Develop New Drugs

The Puget Sound cancer research community has received widespread recognition courtesy of a visit from the U.S Vice President Joe Biden. The research facility is a subsidiary of Seattle Genetics, a leading cancer…

The Success of Seattle Genetics thanks to Clay Siegall

For a new and healthy approach to create a cure for some of the world’s most detrimental diseases, a new treatment has been created that has not only encouraged non-invasive treatments, but has…

Clay Siegall: The Man behind the remarkable growth of Seattle Genetics

Seattle Genetics was founded in 1998. Since then, the company has successfully produced antibody-based therapies for the management of cancer. The company works in close collaboration with principal companies in biotechnology and pharmaceutical fields. Under the leadership of Dr. Siegall, Seattle Genetics recorded a growth of its revenue to more than $675 Million. Dr. Siegall has worked with other pharmaceutical companies such as Alder Biopharmaceuticals, Bristol-Myers Squibb Pharmaceutical Research Institute, and National Cancer Institute. He has also authored more than 70 journals. Currently, Dr. Siegall is a board member of Mima Therapeutics, a biotechnology company based in Texas. In January 2013, the company appointed him as an outside director to its board of trustees. The Company was proud to inaugurate Dr. Clay Siegall due to his wealth of experience working in pharmaceutical industries. Other than his experience, Dr. Siegall had also started an oncology company. His appointment was planned to help the business make desirable growth in the manufacture of microRNA- based therapeutics critical in cancer research. Given Dr. Siegall’s diverse expertise and skills, Mirna Therapeutics Company was confident that he will make remarkable achievements in developing and commercializing its MicroRNA therapeutics. Their products are engineered to address health issues on oncology and other diseases. They also help in suppressing the growth of cancer cells by blocking tumor growth. Their efforts have been supported by private investors and the State of Texas, through the State’s Emerging Technology Fund. Dr. Siegall holds a Bachelor of Science in zoology from the University of Maryland. He further holds a doctorate degree in genetics from George Washington University. For his contributions in the health field, he has received multiple honorary accolades. Clay Siegall’s most recent honorary awards include Alumnus of the year for Computer, Math and Natural Sciences from the University of Maryland and Entrepreneur of the Year from Pacific Northwest Ernst and Young. Given his diverse knowledge on the management of pharmaceutical and biotechnology industries, Dr. Siegall can be termed as a reliable manager who can take the biotechnology innovations to the next step. Sources: http://www.pegsummit.com/uploadedFiles/PEGS/Agenda/15/PEGS-Interview-Siegall.pdf http://www.mirnatherapeutics.com/pdfs/releases/2013%200130%20Mirna%20Siegall%20BOD.pdf

Seattle Genetics Is A Leading Company In Cancer Research

Seattle Genetics creates highly effective cancer treatments that have produced excellent, lifesaving results in many patients. It can be expected that these treatments will continue to save many more lives in the future. Clay Siegall has played a key role in making this happen. In fact, he was one of the individuals that started this company. Since he did, he’s done quite to facilitate continued growth of the company. Due to the company’s success, Seattle Genetics also has a great stock for investors to purchase. Given the company’s stability and success, it is expected that their stocks will continue to be a profitable investment. Clay Siegall has a great deal of experience in the business world, and these experiences help him to be a better business leader with Seattle Gentics. He has been with Seattle Genetics, since it’s founding. Additionally, he’s currently on several corporate boards. He serves on the boards of Alder Pharmaceutical, Ultragenyx Pharmaceutical, and Mirna Theraputics. In addition to being a very skilled business leader, Clay Siegall also is a scientist. He is very knowledgeable on the technologies that Seattle Genetics works on. He earned a PHD from The George Washington University in genetics. During his studies, he studied targeted cancer treatment methods in depth. The company works on a high tech type of cancer treatment, referred to as antibody drug conjugates (also referred to as ADCs). One very important advantage that these drugs can have over traditional chemotherapy methods is that they discriminate between cancer cells and healthy cells. This can prevent the death of healthy cells that would be killed by traditional chemotherapy methods. There are benefits to this type of therapy for the health of the patients receiving it. Seattle Genetics is known as the leader in the research on this new, high tech treatment for cancer. As time goes on, Seattle Genetics is likely to make many new discoveries to advance this new and improved cancer treatment. This will likely improve and lengthen the lives of many people that have been affected by cancer. References: https://www.linkedin.com/in/claysiegall http://www.seattlegenetics.com/